Long-term Conventionally Dosed Vancomycin Therapy In Patients With Orthopaedic Implant-related Infections Seems As Effective And Safe As Long-term Penicillin Or Clindamycin Therapy. A Retrospective Cohort Study Of 103 Patients

Journal of Bone and Joint Infection
Jacomien AlemanEric J F Franssen

Abstract

Objectives: Antimicrobial therapy is one of the cornerstones of orthopaedic implant-related infections (OIRI) treatment. Infections with Gram-positive bacteria are often treated with vancomycin, penicillin or clindamycin. A recent IDSA guideline suggests increasing the dose of vancomycin to increase the trough vancomycin target serum concentrations. This is deemed necessary because of an observed decrease in vancomycin susceptibility among Gram-positive bacteria. However, elevated vancomycin concentrations are correlated with the risk of nephrotoxicity, especially with prolonged therapy. Compared to most countries, rates of resistance against antibiotics among bacteria in the Netherlands are lower for currently available antibiotics, therefore lower target concentrations of vancomycin are probably efficacious for the treatment of infections. In this study we evaluated the efficacy and safety of long-term conventionally dosed vancomycin therapy, as an initial therapy for OIRI, and compared this with long-term penicillin and clindamycin therapy, as initial therapy, in patients with Gram-positive orthopaedic implant-related infections. Methods: A retrospective, observational study was conducted in 103 adult patients treated for OI...Continue Reading

References

Oct 16, 2004·The New England Journal of Medicine·Werner ZimmerliPeter E Ochsner
Nov 22, 2005·Infectious Disease Clinics of North America·Irene G SiaAdolf W Karchmer
Jan 18, 2006·The Journal of Antimicrobial Chemotherapy·Göran KronvallLennart E Nilsson
Dec 25, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michael RybakDonald P Levine
Mar 14, 2012·European Journal of Clinical Pharmacology·Sepideh ElyasiAmirhooshang Mohammadpour
Dec 13, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V DubéeN Desplaces
Oct 30, 2013·Antimicrobial Agents and Chemotherapy·Michael N NeelyThomas P Lodise
Jan 31, 2014·Frontiers in Public Health·Christina Maria Joseph Elisabeth Vandenbroucke-Grauls
Nov 7, 2014·Critical Reviews in Toxicology·Glen J Van Der KraakKeith R Solomon

❮ Previous
Next ❯

Citations

Nov 16, 2018·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·UNKNOWN ALSUntangled Group, Richard Bedlack

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Vinícius S ColaresRegina C R M Abdulkader
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Matthew L BrownDarrell T Childress
© 2022 Meta ULC. All rights reserved